The Asia Pacific Coronary Artery Bypass Graft Market should witness market growth of 10.0% CAGR during the forecast period (2023-2029).
Cardiothoracic surgeons can conduct coronary artery bypass grafts skilfully and minimally invasively using the robotic surgical system. The market will expand due to the popularity of robotic minimally invasive CABG treatments such as robotic internal thoracic artery harvesting, robotic assistance coronary artery bypass graft, and entirely robotic coronary artery bypass graft.
Less invasive procedures have been developed to bypass clogged coronary arteries, even though the traditional "open heart" treatment is still often performed and frequently preferred in many instances. The heart does not need to be halted for "off-pump" treatments. It is also possible to use robotic operations and other minimally invasive techniques like keyhole surgery, performed through very small incisions.
The population of China is aging quickly; due to increased life expectancy and declining birth rates, the proportion of people over 60 is predicted to reach 28% by 2040. This tremendous demographic transformation makes it possible to develop an integrated system that satisfies older people's social and health needs while guaranteeing that all individuals have access to health care irrespective of geography. Additionally, Japan's population is aging swiftly; in 2017, there were 27.7% of residents over 65. This percentage will steadily rise, reaching 38.4% in 2065. According to the 2011 Census, 8.6% of India's population, or 104 million people, are 60 or older. The probability of serious diseases such as heart blockage is predicted to rise as the population ages, increasing demand.
The China market dominated the Asia Pacific Coronary Artery Bypass Graft Market by Country in 2022 and would continue to be a dominant market till 2029; thereby, achieving a market value of $1,356.1 million by 2029. The Japan market is poised to grow at a CAGR of 9.3% during (2023-2029). Additionally, The India market would showcase a CAGR of 10.7% during (2023-2029).
Based on Procedure, the market is segmented into Single CABG Surgery, Double CABG Surgery, Triple CABG Surgery, and Quadruple CABG Surgery. Based on Method, the market is segmented into Off-pump, On-pump, and Minimally Invasive Direct. Based on End-use, the market is segmented into Hospitals, Cardiology Centers, and Others. Based on countries, the market is segmented into China, Japan, India, South Korea, Singapore, Malaysia, and Rest of Asia Pacific.
The market research report covers the analysis of key stake holders of the market. Key companies profiled in the report include Medtronic PLC, Terumo Corporation, Karl Storz SE & Co. KG, Edwards Lifesciences Corporation, Johnson & Johnson (Ethicon, Inc.), Boston Scientific Corporation, Stryker Corporation, LivaNova PLC, Genesee BioMedical, Inc., and Vitalitec International Medizintechnik GmbH (Peters Surgical)
Cardiothoracic surgeons can conduct coronary artery bypass grafts skilfully and minimally invasively using the robotic surgical system. The market will expand due to the popularity of robotic minimally invasive CABG treatments such as robotic internal thoracic artery harvesting, robotic assistance coronary artery bypass graft, and entirely robotic coronary artery bypass graft.
Less invasive procedures have been developed to bypass clogged coronary arteries, even though the traditional "open heart" treatment is still often performed and frequently preferred in many instances. The heart does not need to be halted for "off-pump" treatments. It is also possible to use robotic operations and other minimally invasive techniques like keyhole surgery, performed through very small incisions.
The population of China is aging quickly; due to increased life expectancy and declining birth rates, the proportion of people over 60 is predicted to reach 28% by 2040. This tremendous demographic transformation makes it possible to develop an integrated system that satisfies older people's social and health needs while guaranteeing that all individuals have access to health care irrespective of geography. Additionally, Japan's population is aging swiftly; in 2017, there were 27.7% of residents over 65. This percentage will steadily rise, reaching 38.4% in 2065. According to the 2011 Census, 8.6% of India's population, or 104 million people, are 60 or older. The probability of serious diseases such as heart blockage is predicted to rise as the population ages, increasing demand.
The China market dominated the Asia Pacific Coronary Artery Bypass Graft Market by Country in 2022 and would continue to be a dominant market till 2029; thereby, achieving a market value of $1,356.1 million by 2029. The Japan market is poised to grow at a CAGR of 9.3% during (2023-2029). Additionally, The India market would showcase a CAGR of 10.7% during (2023-2029).
Based on Procedure, the market is segmented into Single CABG Surgery, Double CABG Surgery, Triple CABG Surgery, and Quadruple CABG Surgery. Based on Method, the market is segmented into Off-pump, On-pump, and Minimally Invasive Direct. Based on End-use, the market is segmented into Hospitals, Cardiology Centers, and Others. Based on countries, the market is segmented into China, Japan, India, South Korea, Singapore, Malaysia, and Rest of Asia Pacific.
The market research report covers the analysis of key stake holders of the market. Key companies profiled in the report include Medtronic PLC, Terumo Corporation, Karl Storz SE & Co. KG, Edwards Lifesciences Corporation, Johnson & Johnson (Ethicon, Inc.), Boston Scientific Corporation, Stryker Corporation, LivaNova PLC, Genesee BioMedical, Inc., and Vitalitec International Medizintechnik GmbH (Peters Surgical)
Scope of the Study
By Procedure
- Single CABG Surgery
- Double CABG Surgery
- Triple CABG Surgery
- Quadruple CABG Surgery
By Method
- Off-pump
- On-pump
- Minimally Invasive Direct
By End-use
- Hospitals
- Cardiology Centers
- Others
By Country
- China
- Japan
- India
- South Korea
- Singapore
- Malaysia
- Rest of Asia Pacific
Key Market Players
List of Companies Profiled in the Report:
- Medtronic PLC
- Terumo Corporation
- Karl Storz SE & Co. KG
- Edwards Lifesciences Corporation
- Johnson & Johnson (Ethicon, Inc.)
- Boston Scientific Corporation
- Stryker Corporation
- LivaNova PLC
- Genesee BioMedical, Inc.
- Vitalitec International Medizintechnik GmbH (Peters Surgical)
Unique Offerings
- Exhaustive coverage
- The highest number of Market tables and figures
- Subscription-based model available
- Guaranteed best price
- Assured post sales research support with 10% customization free
Table of Contents
Chapter 1. Market Scope & Methodology
Chapter 2. Market Overview
Chapter 4. Asia Pacific Coronary Artery Bypass Graft Market by Procedure
Chapter 5. Asia Pacific Coronary Artery Bypass Graft Market by Method
Chapter 6. Asia Pacific Coronary Artery Bypass Graft Market by End-use
Chapter 7. Asia Pacific Coronary Artery Bypass Graft Market by Country
Chapter 8. Company Profiles
Companies Mentioned
- Medtronic PLC
- Terumo Corporation
- Karl Storz SE & Co. KG
- Edwards Lifesciences Corporation
- Johnson & Johnson (Ethicon, Inc.)
- Boston Scientific Corporation
- Stryker Corporation
- LivaNova PLC
- Genesee BioMedical, Inc.
- Vitalitec International Medizintechnik GmbH (Peters Surgical)
Methodology
LOADING...
